Urorec (silodosin)
- Region
- 🇪🇺 EU
- Active substance
- silodosin
- Company
- Recordati Ireland Ltd
- Status
- Authorised
- Therapeutic area
- Prostatic Hyperplasia
- CHMP opinion
- Thu 19 Nov 2009
- EU approval
- Fri 29 Jan 2010
- Application
- EMEA/H/C/001092
- ATC
- G04CA04
- Official record
- www.ema.europa.eu
Indication
Treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Silodyx Authorised · Recordati Ireland Ltd
- 🇪🇺 Silodosin Recordati Authorised · Recordati Ireland Ltd
Follow Urorec
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.